Immunocore Holdings plc
- IMCR
- NASDAQ
- Biotechnology
- TCR Immunotherapy
- Immuno-Oncology
$29.84
Today +1.50%Quote Oct 19, 2026, 08:00 PM UTC
−6.75%over the last month
Max drawdown −14.2%From 1-month high −8.0%3 months −13.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Immunocore
Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
524
Market value
$1.54B
Quote Oct 19
Floor
$29.02
2.7% below price
Resistance
$29.80
Price is above this level
Price vs analyst targets
14 analysts
Lowest target
$35.00Highest target
$43.00
$35.00Highest target
$43.00
- Price $29.84
- Average target $39.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 31% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IMCRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free